The probability that a man develops prostate cancer during his lifetime was 11.2 percent from 2013 to 2015. However, the probability of surviving at least the first five years after diagnosis is extremely high, depending on the stage at diagnosis. Those diagnosed at the local and regional stages have a 99 percent chance of surviving the first five years, though this drops to only 30 percent for those diagnosed at the distant stage. The death rate from prostate cancer has generally decreased over the last two decades and was estimated at 19.3 deaths per 100,000 population in 2016. Although prostate cancer is the most common type of cancer among men, it is the second deadliest, behind lung and bronchus cancer.
The risk of prostate cancer is thought to be decreased through a healthy diet, exercise, and healthy weight. Regular prostate cancer screenings are not recommended for younger men who do not show any symptoms, but should be considered for men aged 50 years and above. In 2015, just over 41 percent of men aged 65 years and older reported having a prostate cancer test within the past year. Once diagnosed, the most common type of treatment among men 65 to 74 years is radiation therapy, while radical prostatectomy, or removal of the prostate along with nearby tissue, with and without radiation therapy, is the most common type of treatment among men aged 18 to 64 years.